MX9706825A - El uso farmacologico de ciertos derivados de cistina. - Google Patents
El uso farmacologico de ciertos derivados de cistina.Info
- Publication number
- MX9706825A MX9706825A MX9706825A MX9706825A MX9706825A MX 9706825 A MX9706825 A MX 9706825A MX 9706825 A MX9706825 A MX 9706825A MX 9706825 A MX9706825 A MX 9706825A MX 9706825 A MX9706825 A MX 9706825A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmacological use
- cystine derivatives
- certain
- derivatives
- certain cystine
- Prior art date
Links
- LEVWYRKDKASIDU-IMJSIDKUSA-N cystine group Chemical class C([C@@H](C(=O)O)N)SSC[C@@H](C(=O)O)N LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 title abstract 2
- 230000000144 pharmacologic effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 208000037803 restenosis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Se describe un método para el tratamiento de la restenosis usando ciertos derivados de cistina y una preparacion farmacéutica que comprende éstos derivados.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9500897.5 | 1995-03-14 | ||
SE9500897A SE9500897D0 (sv) | 1995-03-14 | 1995-03-14 | The pharmacological use of certain cystine derivatives |
PCT/SE1996/000320 WO1996028149A1 (en) | 1995-03-14 | 1996-03-12 | The pharmacological use of certain cystine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9706825A true MX9706825A (es) | 1997-11-29 |
MXPA97006825A MXPA97006825A (es) | 1998-07-03 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
CZ288219B6 (en) | 2001-05-16 |
CA2214831A1 (en) | 1996-09-19 |
AU701287B2 (en) | 1999-01-21 |
EP0814798A1 (en) | 1998-01-07 |
IL117465A0 (en) | 1996-07-23 |
UA42830C2 (uk) | 2001-11-15 |
NO974143D0 (no) | 1997-09-09 |
WO1996028149A1 (en) | 1996-09-19 |
JPH11501916A (ja) | 1999-02-16 |
AR002716A1 (es) | 1998-04-29 |
AU5018596A (en) | 1996-10-02 |
EE03382B1 (et) | 2001-04-16 |
TW385249B (en) | 2000-03-21 |
PL322328A1 (en) | 1998-01-19 |
SE9500897D0 (sv) | 1995-03-14 |
NO974143L (no) | 1997-09-09 |
HUP9801985A3 (en) | 2000-07-28 |
ZA961749B (en) | 1996-09-16 |
US5883126A (en) | 1999-03-16 |
IS4554A (is) | 1997-08-27 |
CZ280497A3 (cs) | 1998-01-14 |
PL183234B1 (pl) | 2002-06-28 |
EE9700229A (et) | 1998-04-15 |
SK282448B6 (sk) | 2002-02-05 |
CN1183718A (zh) | 1998-06-03 |
NZ303781A (en) | 2001-03-30 |
BR9607225A (pt) | 1998-07-07 |
TR199700945T1 (xx) | 1998-02-21 |
KR19980703055A (ko) | 1998-09-05 |
SK120797A3 (en) | 1998-02-04 |
HUP9801985A2 (hu) | 1998-12-28 |
IL117465A (en) | 2000-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7578696A (en) | Morpholine derivatives and their use as therapeutic agents | |
HUP9601492A3 (en) | Benzimidazol derivatives, process for producing them and pharmaceutical use of them | |
HUP9801230A3 (en) | Benzopyran-derivatives and their use for the production of medicaments for treating estrogen sensitive diseases | |
MX9700082A (es) | Composicion que consiste de morfina, polipirrolidona y oxido de polialquileno. | |
ZA961150B (en) | Substituted isoxazoles for the treatment of inflammation. | |
BG101901A (en) | 2-methyl-thieno-benzodiazepine formulation for oral application | |
IL117957A0 (en) | Pharmaceutical compositions for the treatment of impotence | |
MX9701342A (es) | Formulacion cosolvente de tirilazad para administracion parenteral. | |
PL323726A1 (en) | Novel derivatives of dolastatin, their production and application | |
AU7678096A (en) | Therapeutic medical garments for scars and process | |
HU9402832D0 (en) | Imidazol-4-yl-piperidine derivatives, process for producing them and pharmaceutical use of them | |
MX9704030A (es) | 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos. | |
EP0751170A3 (en) | Compounds derived from a silicone, their preparation and use | |
WO1993000094A3 (en) | Use of tetrahydrobenzazepine derivatives for the treatment of portal hypertension and migraine | |
HU9503848D0 (en) | 3-phenyl-izoquinolin-(2h)-one derivatives, process for producing them and pharmaceutical use of them | |
PL323177A1 (en) | Azacycloalcane derivatives, method of obtaining them and their application for therapeutic purposes | |
MY129782A (en) | Novel medical use | |
AU7310896A (en) | Use of nitroflavonoids for the treatment of anxiety | |
GB9508823D0 (en) | Drug Derivatives | |
IL115320A0 (en) | Retinoyloxy (substituted) methyl butyrates useful for the treatment of cancer and other proliferative diseases | |
HK1014938A1 (en) | Oxazolidinone derivatives, their preparation and therapeutical use | |
AU3909389A (en) | Il-1alpha derivatives and medicament for treating thrombocytopenia | |
ZA964198B (en) | Treatment regime for skin. | |
AU6406098A (en) | Use of minalcipran and its derivatives for preparing a medicine for treating certain psychiatric diseases | |
TW330933B (en) | Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes |